Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines     Toxoid vaccines    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Toxoid vaccines Market Research Report

  • Report Code: TO 1001
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The European Toxoid Animal Vaccine Market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans and the prevalence of tetanus and diphtheria diseases. This market was valued at $177.9 million in 2013 and expected to reach $222.4 million by 2018 at a CAGR of 4.6%.

 

 “The European Toxoid Animal Vaccine Market, 2012-2018” analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. All these products have experienced positive growth because of increased awareness for procedures and sophisticated diagnostic techniques. These vaccines are used when a bacterial toxin is the main cause of illness. Scientists have found that they can inactivate toxins by treating them with formalin, a solution of formaldehyde and sterilized water. Such “detoxified” toxins, called toxoids, and are safe for use in vaccines.

 

Adacel, Boostrix, Decavac, and MassBiologics are a few examples of toxoid vaccines.

 

Europe is the fastest growing market owing to highly organized livestock sector. This growth is attributed to its highly organized livestock farms and the huge demand for livestock products, such as food (meat, egg, milk, and its byproducts) and non-food items from the European population. The demand for livestock products is high in European countries. For example, beef imports in the European Union (EU) increased by 5% from 2012 to 2013 to a total of 187,974 tones.

 

This report also provides an extensive competitive landscaping of companies operating in this market. The main companies are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.

 

 Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

 

Customization Options:

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • End-user Adoption rate analysis of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

 

Epidemiology Data

  • Country specific Prevalence of tetanus and Diphtheria diseases.
  •  Country specific Patient pool of tetanus and Diphtheria diseases.
  • Disease progression (Pattern analysis)

 

Surgeons/Physicians Perception Analysis

  • Fast turn-around analysis of Surgeons response to market events and trends
  • Pattern analysis of usage of Toxoid vaccines by Physicians
  • Surgeons’ opinion about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Brand/ Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

 

Competitive Intelligence

  • The company share analysis of Toxoid Animal Vaccine Market for the top players of the market in the region.
  • The crucial developments and strategies of companies inculcating in their portfolio for Toxoid Animal Vaccine Market

 

Alternative Products: Impact analysis

MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and clinics, diagnosis rate, treatment rate and healthcare expenditure)



1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Toxoid vaccines-Europe, By Types
4.1 Split By Geography
4.1 Toxoid vaccines-Europe - Other Geographies by Types
4.1 Toxoid vaccines-United Kingdom by Types
4.1 Toxoid vaccines-France by Types
4.1 Toxoid vaccines-Germany by Types
4.1 Toxoid vaccines-Italy by Types
4.1 Toxoid vaccines-Spain by Types
4.2 Toxoid vaccines-Preventive-Europe
4.2.1 Toxoid vaccines-Preventive-Europe, By Geographies
4.2.1.1 Toxoid vaccines-Preventive-United Kingdom
4.2.1.2 Toxoid vaccines-Preventive-France
4.2.1.3 Toxoid vaccines-Preventive-Germany
4.2.1.4 Toxoid vaccines-Preventive-Italy
4.2.1.5 Toxoid vaccines-Preventive-Spain
4.2.1.6 Toxoid vaccines-Preventive-Europe - Other Geographies
4.3 Toxoid vaccines-Therapeutic-Europe
4.3.1 Toxoid vaccines-Therapeutic-Europe, By Geographies
4.3.1.1 Toxoid vaccines-Therapeutic-United Kingdom
4.3.1.2 Toxoid vaccines-Therapeutic-France
4.3.1.3 Toxoid vaccines-Therapeutic-Germany
4.3.1.4 Toxoid vaccines-Therapeutic-Italy
4.3.1.5 Toxoid vaccines-Therapeutic-Spain
4.3.1.6 Toxoid vaccines-Therapeutic-Europe - Other Geographies
5 Toxoid vaccines-Europe, By Geographies
5.1 Toxoid vaccines-Europe - Other Geographies
5.1.1 Toxoid vaccines-Europe - Other Geographies, By Types
5.1.1.1 Toxoid vaccines-Preventive-Europe - Other Geographies
5.1.1.2 Toxoid vaccines-Therapeutic-Europe - Other Geographies
5.2 Toxoid vaccines-United Kingdom
5.2.1 Toxoid vaccines-United Kingdom, By Types
5.2.1.1 Toxoid vaccines-Preventive-United Kingdom
5.2.1.2 Toxoid vaccines-Therapeutic-United Kingdom
5.3 Toxoid vaccines-France
5.3.1 Toxoid vaccines-France, By Types
5.3.1.1 Toxoid vaccines-Preventive-France
5.3.1.2 Toxoid vaccines-Therapeutic-France
5.4 Toxoid vaccines-Germany
5.4.1 Toxoid vaccines-Germany, By Types
5.4.1.1 Toxoid vaccines-Preventive-Germany
5.4.1.2 Toxoid vaccines-Therapeutic-Germany
5.5 Toxoid vaccines-Italy
5.5.1 Toxoid vaccines-Italy, By Types
5.5.1.1 Toxoid vaccines-Preventive-Italy
5.5.1.2 Toxoid vaccines-Therapeutic-Italy
5.6 Toxoid vaccines-Spain
5.6.1 Toxoid vaccines-Spain, By Types
5.6.1.1 Toxoid vaccines-Preventive-Spain
5.6.1.2 Toxoid vaccines-Therapeutic-Spain

Please fill in the form below to receive a free copy of the Summary of this Report
















European Toxoid vaccines Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539